Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tenon Medical (TNONW) EBITDA (2021 - 2025)

Historic EBITDA for Tenon Medical (TNONW) over the last 5 years, with Q3 2025 value amounting to -$3.3 million.

  • Tenon Medical's EBITDA fell 486.81% to -$3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.8 million, marking a year-over-year increase of 592.6%. This contributed to the annual value of -$13.6 million for FY2024, which is 1223.67% up from last year.
  • Latest data reveals that Tenon Medical reported EBITDA of -$3.3 million as of Q3 2025, which was down 486.81% from -$2.8 million recorded in Q2 2025.
  • Over the past 5 years, Tenon Medical's EBITDA peaked at -$201000.0 during Q1 2021, and registered a low of -$7.8 million during Q4 2022.
  • Over the past 5 years, Tenon Medical's median EBITDA value was -$3.2 million (recorded in 2022), while the average stood at -$3.4 million.
  • Its EBITDA has fluctuated over the past 5 years, first plummeted by 107064.68% in 2022, then soared by 6072.48% in 2023.
  • Quarter analysis of 5 years shows Tenon Medical's EBITDA stood at -$2.8 million in 2021, then plummeted by 175.76% to -$7.8 million in 2022, then skyrocketed by 60.72% to -$3.1 million in 2023, then fell by 0.29% to -$3.1 million in 2024, then decreased by 8.16% to -$3.3 million in 2025.
  • Its EBITDA stands at -$3.3 million for Q3 2025, versus -$2.8 million for Q2 2025 and -$3.6 million for Q1 2025.